Braavos Investment Advisers

Founded in 2019, Braavos Investment Advisers is a venture capital firm based in London, United Kingdom. It focuses on investing in early-to-growth-stage science and technology companies.

Andre Crawford-Brunt

General Partner

8 past transactions

PQShield

Series B in 2024
PQShield specializes in post-quantum cryptography solutions, safeguarding global technology infrastructures against future quantum computing threats. Founded in 2018 and based in Oxford, UK, the company offers hardware, software, and cloud-based implementations, leading standardization efforts worldwide.

OxCCU

Series A in 2023
OxCCU develops renewable energy technology to enable a circular economy for fuels, chemicals, and plastics. The technology combines carbon dioxide from the atmosphere with hydrogen from water and renewable electricity to produce fuels, chemicals, and biodegradable plastics and is positioned to deliver the lowest-cost Power to Liquids pathway.

Oxford Ionics

Series A in 2023
Oxford Ionics specializes in advanced quantum computing systems, focusing on trapped-ion technology. This enables scalable, efficient quantum chips produced via standard semiconductor methods, facilitating advancements in quantum computing and enhancing computational capabilities for complex problems.

Osler Diagnostics

Series C in 2022
Osler Diagnostics is a UK-based company focused on providing accessible and accurate health diagnostics. Founded in 2017 as a spin-off from the University of Oxford, the company has leveraged extensive research in portable diagnostic technologies, originally stemming from the development of the blood glucose sensor. Its flagship product, the Osler Origin, is a portable laboratory capable of delivering lab-quality diagnostics anytime and anywhere, enabling individuals to conduct tests for a variety of health biomarkers using just a drop of blood. This innovative approach aims to decentralize healthcare, making it easier for users to monitor their health and make informed decisions, ultimately supporting healthier and longer lives. Osler Diagnostics is headquartered in Oxford, UK, and aims to serve all major healthcare settings globally.

CHARM Therapeutics

Series A in 2022
CHARM Therapeutics uses 3D deep learning and advanced drug discovery technologies to develop transformational medicines for diseases that are difficult to treat, aiming to enable clinicians to target undruggable disease targets with novel therapies that offer potentially life-changing efficacy.

First Light Fusion

Series C in 2022
First Light Fusion Limited is a UK-based company that specializes in researching advanced implosion processes aimed at electricity generation through inertial confinement fusion. Founded in 2011 as a spin-out from the University of Oxford, the company focuses on harnessing fundamental physics to explore various innovative energy generation methods. It employs a team of engineers and physicists who engage in theoretical analysis, detailed numerical simulations, and experimental validation to develop new energy sources. First Light Fusion collaborates closely with several academic institutions, including the University of Oxford, Warwick University, University College London, and Imperial College London. The company, originally named Oxyntix Ltd., rebranded in June 2014 to reflect its focus on fusion energy research.

SpyBiotech Limited

Series A in 2021
SpyBiotech Limited is a biotechnology company headquartered in Oxford, United Kingdom, founded in 2017. It develops a proprietary protein superglue technology that bonds antigens to viral or other particle carriers, creating what the company calls bonding vaccines. This platform enables research institutions and medical facilities to design and produce vaccines against infectious diseases and cancer more rapidly and with potentially improved efficacy. By simplifying the assembly of vaccine components, SpyBiotech aims to accelerate the development cycle and reduce time to clinical application.

Stockbit

Series A in 2019
Stockbit is an Indonesian investment community platform that facilitates real-time sharing of stock-related ideas, news, and financial information. It enables users to create profiles, follow specific stocks or investors, and engage in valuable discussions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.